기본 정보
- CAS
105812-85-9- 표준 SMILES
O=C(Oc1ccccc1)N1CC[C@@H](c2ccc(F)cc2)[C@@H](COc2ccc3c(c2)OCO3)C1- InChIKey
XHNUMAXRQGMHKZ-XXBNENTESA-N- 분자식
- C26H24FNO5
- 평균 분자량
- 449.47 g/mol
이름 및 식별자
- 우선 이름
- phenyl (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- fluorophenyl)piperidine-1-carboxylate compound
- 영어명
- phenyl (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- fluorophenyl)piperidine-1-carboxylate compound
- 분자식
- C26H24FNO5
- 분자량
- 449.47
이름 및 동의어
Paroxetine impurities787(cis)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylatephenyl (3RS,4RS)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- fluorophenyl)piperidine-1-carboxylatephenyl (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- fluorophenyl)piperidine-1-carboxylate compound1-Piperidinecarboxylic acid, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, phenyl ester, (3R,4R)-rel-phenyl (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate compound With phenyl (3S,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate (1:1)
데이터베이스 식별자
- CAS
105812-85-9
물성
물리화학적 성질
- 끓는 점
- 574.766 · 574.766±50.00 °C(Press: 760.00 Torr)(predicted)
- 밀도
- 1.285 · 1.285±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
- 산도 계수 (pKa)
- 0.375 · 0.375±0.60(predicted)
화학 및 산업
공급사11 곳
陕西缔都医药有限责任公司029-81124775 17791530730 · [email protected]
怀化元研达生物技术有限责任公司18711085600 · [email protected]
怀化元研达生物技术有限责任公司18711085600; 18229999901 · [email protected]
北京康派森医药科技有限公司010-010-52878169 15801002657 · [email protected]
雷丁试剂0510-85629785 18013409632 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
深圳卓越生物医药科技有限公司26050679 18318671572 · [email protected]
深圳晴天生物技术有限公司18823167005 18162969855 · [email protected]
雷丁科技0510-85629785 18013409632 · [email protected]
深圳瑞恺德生物科技有限公司0755-61348847 17820674378 · [email protected]
Hangzhou Huarong Pharm Co., Ltd.571-86758373 +8613588754946 · [email protected]
관련 반응
0건
현재 필터 조건에 해당하는 반응 기록이 없습니다.
화합물 노트
불러오는 중…